Article

Clinical Outcomes of Genotype-Matched Therapy For Recurrent Gynecological Cancers

2021-07-06

Abstract excerpt

<h4>Background: </h4> Recent advances in next-generation sequencing and genome medicine has contributed to treatment decisions in patients with cancer. Most advanced gynecological cancers develop resistance to chemotherapy and have a poor prognosis. Therefore, we conducted genomic tests in gynecological tumors to examine the efficacy and clinical feasibility of genotype-matched therapy. <h4>Methods: </h4> Target s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc7ce57a-d9ba-5cbf-a732-53c698184e44
DOI: 10.21203/rs.3.rs-590115/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes of Genotype-Matched Therapy For Recurrent Gynecological CancersDOI 10.21203/rs.3.rs-590115/v1Read

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.Semantic proximity Read

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).Semantic proximity Read

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.Semantic proximity Read

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity Read

Biologic therapies and personalized medicine in gynecologic malignancies.Semantic proximity Read

Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.Semantic proximity Read

Druggable gene alterations in Japanese patients with rare malignancy.Semantic proximity Read

Treatment with Antitumor Agents Recommended by Cancer Genome Panel for Uterine LeiomyosarcomaSemantic proximity Read

Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.Semantic proximity Read

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.Semantic proximity Read